Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 1 digital issues and online access to articles $119.00 per year only $119.00 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Results were Achieved with Minimal Safety Concerns
This finding was a result of an analysis conducted on the PIONEER and SUSTAIN serial trials, which studied the drugs effectiveness
One review examined the effect of liraglutide using subgroup analysis according to the population with or without type 2 diabetes mellitus (T2DM), which did not show a significant reduction in HFC [for patients with T2DM: MD = 5.14, 95% CI (11.93, 1.66)
Pregnancy : Not recommended during pregnancy
& Jager, K
